PCV56 Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation Under the Private and Public Health Care System in Brazil

Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.659
https://www.valueinhealthjournal.com/article/S1098-3015(12)00724-3/fulltext
Section Title : Cardiovascular Disorders
Section Order : 134
First Page : A122
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00724-3&doi=10.1016/j.jval.2012.03.659
HEOR Topics :
Tags :
Regions :